Research and innovation news
Keep up-to-date with the latest news, publications and events from the Research and Innovation team at MFT.
Stillbirth Centre Director wins Tommy’s Star Researcher Award
Professor Alex Heazell, Professor of Obstetrics and Director of the Tommy’s Stillbirth Research Centre at Saint Mary’s Hospital has won a Tommy’s Award, presented by baby charity Tommy’s
£18.5m financing announced for Citylabs 2.0 at MFT
A joint venture between MSPL, the leading UK operator of science and technology campuses, and MFT has been awarded an £18m loan for the pioneering Citylabs 2.0 development on Trust campus.
Multi-million pound government award to Manchester health consortium
A Manchester health consortium has been awarded nearly £7 million of funding to ensure more patients benefit from a new generation of disease-fighting drugs for cancer and non-cancer illnesses.
GM Connected Health City: sharing progress & best practice
The Greater Manchester Connected Health City (GM CHC) & Manchester Ecosystem invite you to an event to showcase the progress of the GM CHC, to share best practice & to explore new ways of using data t
Greater Manchester to help beat kidney disease
An NHS-supported scheme is expanding to make it easier than ever for people with kidney disease living in Greater Manchester to take part in health research.
Research Practitioner celebrates 25 years delivering research on International Woman’s Day
On International Women’s Day the achievements of women are celebrated around the world. At MFT this date also marks the 25 year career anniversary of rheumatology research practitioner, Ann McGovern
Professional and personal development training programme for NHS staff
Personal and professional development courses facilitated by the Centre for Academic and Research Development (CARD) at The University of Manchester
A Manchester research team has treated the first two patients outside of the USA in a study looking at a next generation device for the treatment of glaucoma
The Department of Eye Research at Manchester Royal Eye Hospital has treated the first two EU participants on a glaucoma study assessing the 12-month safety and effectiveness of the Hydrus Microstent